Search research articles
Contact Us
Filters
Showing results (991-1000 of 1,033) with videos related to
Page
of 104
Sort By:
Cold Spring Harbor Molecular Case Studies
|
June 17, 2018
Clinical response of the novel activating ALK-I1171T mutation in neuroblastoma to the ALK inhibitor ceritinib
Jikui Guan, Susanne Fransson, Joachim Tetteh Siaw, et al.
British Journal of Cancer
|
June 22, 2018
Circulating biomarkers during treatment in patients with advanced biliary tract cancer receiving cediranib in the UK ABC-03 trial
Alison C Backen, Andre Lopes, Harpreet Wasan, et al.
Oncotarget
|
June 23, 2018
The Nrf2 inhibitor brusatol is a potent antitumour agent in an orthotopic mouse model of colorectal cancer
Jonathan P Evans, Boleslaw K Winiarski, Paul A Sutton, et al.
Oncotarget
|
February 19, 2019
Correction: The Nrf2 inhibitor brusatol is a potent antitumour agent in an orthotopic mouse model of colorectal cancer
Jonathan P Evans, Boleslaw K Winiarski, Paul A Sutton, et al.
The Lancet. Oncology
|
July 17, 2015
Cediranib or placebo in combination with cisplatin and gemcitabine chemotherapy for patients with advanced biliary tract cancer (ABC-03): a randomised phase 2 trial
Juan W Valle, Harpreet Wasan, Andre Lopes, et al.
The EMBO Journal
|
January 7, 2021
ALK ligand ALKAL2 potentiates MYCN-driven neuroblastoma in the absence of ALK mutation
Marcus Borenäs, Ganesh Umapathy, Wei-Yun Lai, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 5, 2023
Colonization With Antibiotic-Resistant Bacteria in a Hospital and Associated Communities in Guatemala: An Antibiotic Resistance in Communities and Hospitals (ARCH) Study
Brooke M Ramay, Carmen Castillo, Laura Grajeda, et al.
Plos One
|
February 3, 2017
Microbiome sharing between children, livestock and household surfaces in western Kenya
Emily Mosites, Matt Sammons, Elkanah Otiang, et al.
Leukemia & Lymphoma
|
January 29, 2021
Haematological malignancy and nosocomial transmission are associated with an increased risk of death from COVID-19: results of a multi-center UK cohort
Talvinder Bhogal, Umair T Khan, Rebecca Lee, et al.
Pediatrics
|
July 27, 2011
A randomized study of a monoclonal antibody (pagibaximab) to prevent staphylococcal sepsis
Leonard E Weisman, Helen M Thackray, Robin H Steinhorn, et al.
Page
of 104
Search research articles
Search
Showing results (991-1000 of 1,033) with videos related to
Sort By:
Page
of 104
Cold Spring Harbor Molecular Case Studies
|
June 17, 2018
Clinical response of the novel activating ALK-I1171T mutation in neuroblastoma to the ALK inhibitor ceritinib
Jikui Guan, Susanne Fransson, Joachim Tetteh Siaw, et al.
British Journal of Cancer
|
June 22, 2018
Circulating biomarkers during treatment in patients with advanced biliary tract cancer receiving cediranib in the UK ABC-03 trial
Alison C Backen, Andre Lopes, Harpreet Wasan, et al.
Oncotarget
|
June 23, 2018
The Nrf2 inhibitor brusatol is a potent antitumour agent in an orthotopic mouse model of colorectal cancer
Jonathan P Evans, Boleslaw K Winiarski, Paul A Sutton, et al.
Oncotarget
|
February 19, 2019
Correction: The Nrf2 inhibitor brusatol is a potent antitumour agent in an orthotopic mouse model of colorectal cancer
Jonathan P Evans, Boleslaw K Winiarski, Paul A Sutton, et al.
The Lancet. Oncology
|
July 17, 2015
Cediranib or placebo in combination with cisplatin and gemcitabine chemotherapy for patients with advanced biliary tract cancer (ABC-03): a randomised phase 2 trial
Juan W Valle, Harpreet Wasan, Andre Lopes, et al.
The EMBO Journal
|
January 7, 2021
ALK ligand ALKAL2 potentiates MYCN-driven neuroblastoma in the absence of ALK mutation
Marcus Borenäs, Ganesh Umapathy, Wei-Yun Lai, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 5, 2023
Colonization With Antibiotic-Resistant Bacteria in a Hospital and Associated Communities in Guatemala: An Antibiotic Resistance in Communities and Hospitals (ARCH) Study
Brooke M Ramay, Carmen Castillo, Laura Grajeda, et al.
Plos One
|
February 3, 2017
Microbiome sharing between children, livestock and household surfaces in western Kenya
Emily Mosites, Matt Sammons, Elkanah Otiang, et al.
Leukemia & Lymphoma
|
January 29, 2021
Haematological malignancy and nosocomial transmission are associated with an increased risk of death from COVID-19: results of a multi-center UK cohort
Talvinder Bhogal, Umair T Khan, Rebecca Lee, et al.
Pediatrics
|
July 27, 2011
A randomized study of a monoclonal antibody (pagibaximab) to prevent staphylococcal sepsis
Leonard E Weisman, Helen M Thackray, Robin H Steinhorn, et al.
Page
of 104